← Back to Search

Behavioural Intervention

Dental Compass for Temporomandibular Joint Disorder

N/A
Recruiting
Led By Kenneth D Reeves, MD
Research Sponsored by Dr. Dean Reeves Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3-6 months
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to see if using the Dental Compass Articular and its software can accurately make therapeutic splints for TMD. Researchers will compare the outcomes of patients using this technology with those receiving standard treatment

Who is the study for?
This trial is for individuals with TMJ dysfunction and pain, specifically those whose CBCT scans show a non-Gelb 4/7 position or less than 1.8 mm space between certain jawbone parts. It's not suitable for people who don't meet these specific scan criteria.
What is being tested?
The study tests if the Dental Compass Articular and its software can accurately create therapeutic splints for TMD compared to traditional methods, looking at treatment efficiency like number of visits and adjustments needed.
What are the potential side effects?
Since this trial involves diagnostic procedures rather than medications, side effects are minimal but may include discomfort from wearing splints or undergoing imaging techniques like CBCT scans.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3-6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3-6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Number of clinic visits
Number of cone beam CTs (CBCTs)
Number of splint modifications
Secondary study objectives
Anterior joint space of 1.8 mm or more achieved during treatment (3D group only)
Gelb 4/7 position achieved during treatment (3D group only)
Improvement in minimum airway diameter
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: 3D Analysis GroupExperimental Treatment1 Intervention
Compass Use
Group II: Manual Analysis CohortActive Control1 Intervention
Manual Use only

Find a Location

Who is running the clinical trial?

Dr. Dean Reeves ClinicLead Sponsor
4 Previous Clinical Trials
135 Total Patients Enrolled
Lourens A. Du PreezUNKNOWN
Kenneth D Reeves, MDPrincipal InvestigatorK. Dean Reeves, M.D., P.A.
~53 spots leftby Nov 2026